ATAI Life Sciences BV (ATAI) support and resistance · rev $4.1M
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
This page maps ATAI Life Sciences BV (ATAI) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
ATAI currently screens at market cap $555.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ATAI 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ATAI quote page for the session range and the stock page for the full model.
Not investment advice.